Latest Share Chat

REMOVE ADS

Engage Xr Regulatory News (EXR)

Engage Xr Information

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes

Get Live Data

0.25 0.00 (0.00%)

Bid:

0.20

Ask:

0.30

Spread: 0.10 (50.00%)

Market Cap: £1.31m

Last checked at -

Intraday Engage Xr Share Chart

REMOVE ADS

Rule 8.3- EXPRO

27 Jun 2008 12:41

RNS Number : 7326X

UBS AG

27 June 2008

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

1. KEY INFORMATION

Name of person dealing (Note 1)	UBS AG London Branch
Company dealt in	Expro International Group Plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	Ord 10p
Date of dealing	26 JUNE 2008

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	625,376	0.57%	0	0.00%
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total	625,376	0.57%	0	0.00%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Class of relevant security:	Details

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of securities	Price per unit (Note 5)
SALE	4658	1610 PENCE
SALE	4655	1611
SALE	73059	1611
SALE	964	1611
SALE	48642	1611
SALE	4655	1611
PURCHASE	4655	1611
SALE	5000	1611
SALE	10521	1611
SALE	30000	1611
SALE	218	1611
PURCHASE	852	1611
SALE	5000	1611
SALE	782	1611
SALE	4218	1611
SALE	10000	1611
SALE	40000	1611
SALE	40000	1611
SALE	14000	1611
SALE	36000	1611
SALE	50000	1611
SALE	25000	1611
SALE	5900	1611
SALE	100000	1611
PURCHASE	850	1611
PURCHASE	150	1611
SALE	850	1611
SALE	150	1611
SALE	50000	1611
SALE	9700	1611
SALE	39300	1611
SALE	132492	1611
SALE	2500	1612
SALE	1467	1612
SALE	1467	1612
SALE	4652	1612
SALE	10998	1612
SALE	14000	1612
SALE	3030	1612
SALE	1000	1612
SALE	92491	1612
SALE	30000	1612
SALE	9479	1612
SALE	30000	1613
SALE	1576	1613
SALE	18424	1613
PURCHASE	4649	1613
SALE	4649	1613
SALE	32000	1613
SALE	4649	1613
SALE	13351	1613
SALE	1510	1613
PURCHASE	4646	1614
PURCHASE	4646	1614
SALE	4646	1614
SALE	2000	1614
PURCHASE	4643	1615
PURCHASE	4643	1615
PURCHASE	91	1617
PURCHASE	386	1617
PURCHASE	964	1620
PURCHASE	800	1620
SALE	2690	1620
SALE	3546	1620
SALE	964	1620
SALE	856	1620
SALE	800	1620
SALE	3546	1620
SALE	459	1620
SALE	459	1620
SALE	3546	1620
SALE	3546	1620
SALE	459	1620
SALE	1511	1620
SALE	3546	1620
SALE	3546	1620
SALE	3546	1620
SALE	459	1620
SALE	1542	1622
SALE	459	1625
SALE	5000	1625
SALE	964	1626
PURCHASE	1077	1628
SALE	209	1629
PURCHASE	584	1630
SALE	1843	1630
SALE	35	1630
SALE	177	1630
SALE	249	1630
PURCHASE	445	1630
PURCHASE	163	1631
SALE	618	1631
PURCHASE	69	1632
PURCHASE	920	1632
SALE	975	1632
SALE	362	1632
SALE	552	1632
SALE	137	1633
SALE	607	1633
PURCHASE	850	1633
SALE	850	1633
PURCHASE	100	1633
PURCHASE	186	1633
PURCHASE	200	1634
PURCHASE	821	1634
PURCHASE	361	1634
SALE	300	1634

TOTAL PURCHASES	37,751

TOTAL SALES	1,078,011

(b) Derivatives transactions (other than options)

Product name, e.g. CFD	Long/short (Note 6)	Number of securities (Note 7)	Price per unit (Note 5)

(i) Writing, selling, purchasing or varying

Product name,e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

……………………………………………………………………

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure	27 JUNE 2008
Contact name	NIMISHA SACHDEV
Telephone number	020 7567 8762
If a connected EFM, name of offeree/offeror with which connected	N/A
If a connected EFM, state nature of connection (Note 10)	N/A

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS

The company news service from the London Stock Exchange

END

RETUBSARWRRNUAR

Date		Source	Headline
3rd Mar 2023	12:00 pm	RNS	Result of EGM
27th Feb 2023	3:45 pm	RNS	Signing of Subscription Agreement and TVR
7th Feb 2023	11:45 am	RNS	Posting of Circular
6th Feb 2023	12:00 pm	RNS	£8.8 million Placing
6th Feb 2023	7:00 am	RNS	Proposed Placing of New Ordinary Shares
31st Jan 2023	11:05 am	RNS	Second Price Monitoring Extn
31st Jan 2023	11:00 am	RNS	Price Monitoring Extension
23rd Jan 2023	7:00 am	RNS	ENGAGE showcases first AI-powered virtual employee
18th Jan 2023	7:00 am	RNS	FY2022 Trading Update and Notice of Results
12th Dec 2022	2:05 pm	RNS	Second Price Monitoring Extn
12th Dec 2022	2:00 pm	RNS	Price Monitoring Extension
12th Dec 2022	11:05 am	RNS	Second Price Monitoring Extn
12th Dec 2022	11:00 am	RNS	Price Monitoring Extension
12th Dec 2022	7:00 am	RNS	Trading Update
21st Nov 2022	7:00 am	RNS	Commercial reseller agreement signed with Lenovo
7th Nov 2022	7:00 am	RNS	Launch of ENGAGE Link & Investor Presentation
28th Sep 2022	11:00 am	RNS	ENGAGE XR to collaborate with Lenovo
21st Sep 2022	2:09 pm	RNS	Holding(s) in Company
13th Sep 2022	7:00 am	RNS	Interim Results
16th Aug 2022	7:00 am	RNS	Investor Presentation
2nd Aug 2022	7:00 am	RNS	Pre-Close Trading Update and Notice of Results
18th Jul 2022	11:00 am	RNS	Directors’ Disclosure
23rd Jun 2022	7:00 am	RNS	ENGAGE & METAVERSE UPDATE
16th Jun 2022	11:58 am	RNS	Result of AGM
16th May 2022	4:11 pm	RNS	Notice of AGM, Posting of Annual Report & Accounts
7th Apr 2022	4:40 pm	RNS	Second Price Monitoring Extn
7th Apr 2022	4:35 pm	RNS	Price Monitoring Extension
7th Apr 2022	7:00 am	RNS	Engage and Victory XR to Launch 10 Metaversities
28th Mar 2022	7:00 am	RNS	New Senior Appointments to help drive US Growth
8th Mar 2022	7:01 am	RNS	Final Results
4th Mar 2022	11:30 am	RNS	AIM Rule 17 Schedule 2(g) Update
16th Feb 2022	7:00 am	RNS	Notice of Results & Investor Presentation
31st Jan 2022	7:00 am	RNS	Pre-Close Trading Update & Directorate Change
23rd Nov 2021	7:00 am	RNS	Directorate Changes
12th Nov 2021	7:00 am	RNS	ENGAGE Update & Investor Presentation
5th Nov 2021	10:24 am	RNS	Exercise of Options
1st Jul 2008	1:02 pm	RNS	Director Dealings
1st Jul 2008	11:16 am	RNS	Scheme Effective
30th Jun 2008	5:52 pm	RNS	Holding(s) in Company
30th Jun 2008	3:03 pm	RNS	Rule 8.3- Expro International
30th Jun 2008	2:19 pm	BUS	Rule 8.3 - Expro International
30th Jun 2008	12:52 pm	RNS	EPT Disclosure - Expro Intern
30th Jun 2008	12:42 pm	RNS	EPT Disclosure - Expro Intl G
30th Jun 2008	12:37 pm	RNS	EPT Disclosure - Expro Intern
30th Jun 2008	12:11 pm	RNS	Rule 8.3- Expro International
30th Jun 2008	11:16 am	RNS	Holding(s) in Company
30th Jun 2008	11:03 am	RNS	Scheme of arrangement
27th Jun 2008	5:01 pm	RNS	Rule 2.10 Announcement
27th Jun 2008	5:00 pm	RNS	Suspension - Expro Internatio
27th Jun 2008	4:01 pm	RNS	Holding(s) in Company

Latest Share Chat

Engage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Intraday Engage Xr Share Chart

Rule 8.3- EXPRO

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending